NM_001159702.3:c.441C>T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001159702.3(FHL1):​c.441C>T​(p.Asp147Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00257 in 1,211,068 control chromosomes in the GnomAD database, including 8 homozygotes. There are 995 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., 57 hem., cov: 23)
Exomes 𝑓: 0.0027 ( 8 hom. 938 hem. )

Consequence

FHL1
NM_001159702.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.351
Variant links:
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant X-136207901-C-T is Benign according to our data. Variant chrX-136207901-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 239009.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-136207901-C-T is described in Lovd as [Benign]. Variant chrX-136207901-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.351 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00156 (176/112899) while in subpopulation NFE AF= 0.00277 (148/53343). AF 95% confidence interval is 0.00241. There are 0 homozygotes in gnomad4. There are 57 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 57 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FHL1NM_001159702.3 linkc.441C>T p.Asp147Asp synonymous_variant Exon 5 of 8 ENST00000394155.8 NP_001153174.1 Q13642-2
FHL1NM_001159699.2 linkc.489C>T p.Asp163Asp synonymous_variant Exon 4 of 6 ENST00000370683.6 NP_001153171.1 Q13642-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FHL1ENST00000394155.8 linkc.441C>T p.Asp147Asp synonymous_variant Exon 5 of 8 5 NM_001159702.3 ENSP00000377710.2 Q13642-2
FHL1ENST00000370683.6 linkc.489C>T p.Asp163Asp synonymous_variant Exon 4 of 6 1 NM_001159699.2 ENSP00000359717.1 Q13642-5

Frequencies

GnomAD3 genomes
AF:
0.00156
AC:
176
AN:
112846
Hom.:
0
Cov.:
23
AF XY:
0.00163
AC XY:
57
AN XY:
34986
show subpopulations
Gnomad AFR
AF:
0.000289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000465
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000733
Gnomad FIN
AF:
0.00177
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00277
Gnomad OTH
AF:
0.000655
GnomAD3 exomes
AF:
0.00165
AC:
303
AN:
183432
Hom.:
1
AF XY:
0.00183
AC XY:
124
AN XY:
67870
show subpopulations
Gnomad AFR exome
AF:
0.000228
Gnomad AMR exome
AF:
0.000401
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000943
Gnomad FIN exome
AF:
0.00375
Gnomad NFE exome
AF:
0.00245
Gnomad OTH exome
AF:
0.00199
GnomAD4 exome
AF:
0.00267
AC:
2936
AN:
1098169
Hom.:
8
Cov.:
31
AF XY:
0.00258
AC XY:
938
AN XY:
363527
show subpopulations
Gnomad4 AFR exome
AF:
0.000303
Gnomad4 AMR exome
AF:
0.000653
Gnomad4 ASJ exome
AF:
0.0000516
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00118
Gnomad4 FIN exome
AF:
0.00336
Gnomad4 NFE exome
AF:
0.00311
Gnomad4 OTH exome
AF:
0.00184
GnomAD4 genome
AF:
0.00156
AC:
176
AN:
112899
Hom.:
0
Cov.:
23
AF XY:
0.00163
AC XY:
57
AN XY:
35049
show subpopulations
Gnomad4 AFR
AF:
0.000289
Gnomad4 AMR
AF:
0.000464
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000735
Gnomad4 FIN
AF:
0.00177
Gnomad4 NFE
AF:
0.00277
Gnomad4 OTH
AF:
0.000647
Alfa
AF:
0.00200
Hom.:
16
Bravo
AF:
0.00131
EpiCase
AF:
0.00207
EpiControl
AF:
0.00184

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 06, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 21, 2020
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
May 20, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 22523091, 19377476) -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

X-linked myopathy with postural muscle atrophy Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Familial hemophagocytic lymphohistiocytosis type 1 Benign:1
Oct 26, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Mar 18, 2019
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
12
DANN
Benign
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149670651; hg19: chrX-135290060; API